Discrete event simulation: the preferred technique for health economic evaluations?
暂无分享,去创建一个
[1] O. Miettinen,et al. Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. , 1989, Journal of clinical epidemiology.
[2] Pierre L'Ecuyer,et al. Efficiency improvement and variance reduction , 1994, Proceedings of Winter Simulation Conference.
[3] J. Banks,et al. Discrete-Event System Simulation , 1995 .
[4] M J Buxton,et al. Modelling in economic evaluation: an unavoidable fact of life. , 1997, Health economics.
[5] J Karnon,et al. Selecting a decision model for economic evaluation: a case study and review , 1998, Health care management science.
[6] R. Lopert,et al. Use of pharmacoeconomics in prescribing research. Part 5: modelling – beyond clinical trials , 2003, Journal of clinical pharmacy and therapeutics.
[7] Uwe Siebert,et al. When should decision-analytic modeling be used in the economic evaluation of health care? , 2003, The European Journal of Health Economics, formerly: HEPAC.
[8] M. Drummond,et al. Whither trial-based economic evaluation for health care decision making? , 2006, Health economics.
[9] David M Eddy,et al. Accuracy versus transparency in pharmacoeconomic modelling: finding the right balance. , 2006, PharmacoEconomics.
[10] S. Chick,et al. A taxonomy of model structures for economic evaluation of health technologies. , 2006, Health economics.
[11] J Jaime Caro,et al. Regarding probabilistic analysis and computationally expensive models: necessary and required? , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] Johan L Severens,et al. Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] J. Caro,et al. Pharmacoeconomic analyses using discrete event simulation , 2012, PharmacoEconomics.
[14] James E. Stahl,et al. Pharmacoeconomics 2008; 26 (2): 131-148 , 2012 .
[15] Dr David M. Eddy. Accuracy versus Transparency in Pharmacoeconomic Modelling , 2012, PharmacoEconomics.